Free Trial

Aura Biosciences (AURA) SEC Filings & 10K Form

$9.27
-0.17 (-1.80%)
(As of 07/24/2024 ET)

Recent Aura Biosciences SEC Filings

DateFilerForm TypeView
06/14/2024
3:37 PM
Aura Biosciences (Filer)
Form 10-K/A
06/14/2024
3:42 PM
Aura Biosciences (Filer)
Form DEFA14A
05/09/2024
6:05 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:10 AM
Aura Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/07/2024
11:15 PM
Aura Biosciences (Filer)
Form EFFECT
04/04/2024
3:10 PM
Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:59 AM
Aura Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/27/2024
7:12 AM
Aura Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2024
6:11 AM
Aura Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
6:05 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:22 PM
Aura Biosciences (Subject)
Rich Cadmus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:57 PM
Aura Biosciences (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SC 13G/A
02/07/2024
6:54 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aura Biosciences (Subject)
Form SC 13G/A
01/24/2024
3:20 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:31 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:29 PM
Aura Biosciences (Subject)
Rich Cadmus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2023
3:30 PM
Aura Biosciences (Subject)
Rich Cadmus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
3:20 PM
Aura Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
5:09 PM
Aura Biosciences (Issuer)
Feder Julie B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
5:19 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
3:55 PM
Aura Biosciences (Filer)
Form 424B5
11/06/2023
3:17 PM
Aura Biosciences (Filer)
Form 424B5
11/06/2023
3:20 PM
Aura Biosciences (Subject)
Feder Julie B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
3:22 PM
Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
5:21 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
5:24 PM
Aura Biosciences (Issuer)
Feder Julie B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:51 PM
Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/05/2023
6:56 PM
Aura Biosciences (Issuer)
Johnson David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:11 PM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:05 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:10 AM
Aura Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AURA) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners